MENU
+Compare
GLMD
Stock ticker: NASDAQ
AS OF
Sep 18, 02:57 PM (EDT)
Price
$1.52
Change
+$0.03 (+2.01%)
Capitalization
8.11M

GLMD Galmed Pharmaceuticals Ltd Forecast, Technical & Fundamental Analysis

Galmed Pharmaceuticals Ltd is a biopharmaceutical company... Show more

GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GLMD with price predictions
Sep 17, 2025

GLMD's RSI Oscillator ascending out of oversold territory

The RSI Indicator for GLMD moved out of oversold territory on September 03, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 47 similar instances when the indicator left oversold territory. In of the 47 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 09, 2025. You may want to consider a long position or call options on GLMD as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GLMD just turned positive on September 05, 2025. Looking at past instances where GLMD's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GLMD advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 41 cases where GLMD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GLMD broke above its upper Bollinger Band on September 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GLMD entered a downward trend on September 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.396) is normal, around the industry mean (19.637). P/E Ratio (0.019) is within average values for comparable stocks, (53.583). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.168). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (331.570).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GLMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GLMD is expected to report earnings to rise 25.40% to -79 cents per share on November 10

Galmed Pharmaceuticals Ltd GLMD Stock Earnings Reports
Q3'25
Est.
$-0.79
Q2'25
Beat
by $0.20
Q3'23
Beat
by $0.03
Q2'23
Est.
$-0.34
Q1'23
Beat
by $0.41
The last earnings report on August 28 showed earnings per share of -62 cents, beating the estimate of -82 cents. With 50.10K shares outstanding, the current market capitalization sits at 8.11M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
16 Tiomkin Street
Phone
+972 36938448
Employees
10
Web
https://www.galmedpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFGC108.723.98
+3.80%
Performance Food Group Company
IQ2.670.02
+0.94%
iQIYI
HIHO1.730.02
+0.88%
Highway Holdings Limited
ASPN6.60-0.10
-1.49%
Aspen Aerogels
SHIM2.95-0.17
-5.45%
Shimmick Corp

GLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with XBIO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
+0.34%
XBIO - GLMD
88%
Closely correlated
+1.08%
JSPR - GLMD
31%
Poorly correlated
-3.70%
CDTX - GLMD
28%
Poorly correlated
+0.32%
CRVS - GLMD
28%
Poorly correlated
+0.87%
IOBT - GLMD
28%
Poorly correlated
-0.87%
More